摘要 |
FIELD: organic chemistry. SUBSTANCE: invention relates to derivative of (1-heteroazolyl-1-hetero- -cycloalkyl)-alkane of the general formula (I) <EMI ID=0.344 HE=15 WI=54 TI=CHI> where X - oxygen or sulfur; Z - O, S, N-R<SB>2</SB> or C= N; R<SB>1</SB> - H, alkyl, halogen, or R<SB>1</SB> and a ring <EMI ID=0.345 HE=12 WI=9 TI=CHI> form together benzofuran ring system; R<SB>2</SB> - H, lower alkyl, alkoxyalkyl, hydroxyalkyl, acylhydroxyalkyl or CF<SB>3</SB>;; A-<EMI ID=0.346 HE=6 WI=15 TI=CHI> or <EMI ID=0.347 HE=6 WI=21 TI=CHI>; W-O, NH; R<SB>3</SB> -H, lower alkil or acyl; R<SB>4</SB> is alkyl, cyclopropyl or perfluoroalkyl, or R<SB>3</SB> and R<SB>4</SB> form together a ring <EMI ID=0.348 HE=12 WI=24 TI=CHI> where n = 4; R<SB>5</SB> and R<SB>6</SB> - H or lower alkyl or its heometric or optic isomers or racemates, for exception of 1-(4-pyridyl)-1- -(2-thiazolyl)-ethanol and 1-(2-pyridyl)-1-(2-thiazolyl)-ethanol. Compounds of the formula (I) are valuable for treatment of patients with acute and chronic neuropsychiatric processes leading to dying off and dysfunction of nervous cells. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 12 cl, 1 tbl, 76 exI
|